These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21232585)

  • 21. Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size.
    Usmani OS; Biddiscombe MF; Barnes PJ
    Am J Respir Crit Care Med; 2005 Dec; 172(12):1497-504. PubMed ID: 16192448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of regional aerosol deposition patterns as a function of aerodynamic particle size in rhesus macaques using PET/CT imaging.
    Dabisch PA; Xu Z; Boydston JA; Solomon J; Bohannon JK; Yeager JJ; Taylor JR; Reeder RJ; Sayre P; Seidel J; Mollura DJ; Hevey MC; Jahrling PB; Lackemeyer MG
    Inhal Toxicol; 2017 Sep; 29(11):506-515. PubMed ID: 29224407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical relevance of dry powder inhaler performance for drug delivery.
    Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
    Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing sinus aerosol deposition: benefits of SPECT-CT imaging.
    Leclerc L; Pourchez J; Prevot N; Vecellio L; Le Guellec S; Cottier M; Durand M
    Int J Pharm; 2014 Feb; 462(1-2):135-41. PubMed ID: 24374606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lung imaging - two dimensional gamma scintigraphy, SPECT, CT and PET.
    Conway J
    Adv Drug Deliv Rev; 2012 Mar; 64(4):357-68. PubMed ID: 22310158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro/in vivo comparisons in pulmonary drug delivery.
    Newman SP; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):77-84. PubMed ID: 18518834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric in vitro and in silico models of deposition via oral and nasal inhalation.
    Carrigy NB; Ruzycki CA; Golshahi L; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):149-69. PubMed ID: 24870701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of regional and local deposition of inhaled aerosol drugs in the respiratory system by computational fluid and particle dynamics methods.
    Farkas A; Balásházy I; Szocs K
    J Aerosol Med; 2006; 19(3):329-43. PubMed ID: 17034308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment methods of inhaled aerosols: technical aspects and applications.
    Jaafar-Maalej C; Andrieu V; Elaissari A; Fessi H
    Expert Opin Drug Deliv; 2009 Sep; 6(9):941-59. PubMed ID: 19637979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical perspectives on pulmonary systemic and macromolecular delivery.
    Scheuch G; Kohlhaeufl MJ; Brand P; Siekmeier R
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):996-1008. PubMed ID: 16996638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary targeting of nanoparticle drug matrices.
    Dandekar P; Venkataraman C; Mehra A
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):343-53. PubMed ID: 20455773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Particle engineering for pulmonary drug delivery.
    Chow AH; Tong HH; Chattopadhyay P; Shekunov BY
    Pharm Res; 2007 Mar; 24(3):411-37. PubMed ID: 17245651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using MRI to measure aerosol deposition.
    Thompson RB; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):55-62. PubMed ID: 22463490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Particle characteristics and lung deposition patterns in a human airway replica of a dry powder formulation of polylactic acid produced using supercritical fluid technology.
    Cheng YS; Yazzie D; Gao J; Muggli D; Etter J; Rosenthal GJ
    J Aerosol Med; 2003; 16(1):65-73. PubMed ID: 12737686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Particle size-dependent total mass deposition in lungs determines inhalation toxicity of cadmium chloride aerosols in rats. Application of a multiple path dosimetry model.
    Cassee FR; Muijser H; Duistermaat E; Freijer JJ; Geerse KB; Marijnissen JC; Arts JH
    Arch Toxicol; 2002 Jun; 76(5-6):277-86. PubMed ID: 12107645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Particle transport onto human airway surfaces.
    Heyder J
    Eur J Respir Dis Suppl; 1982; 119():29-50. PubMed ID: 6954086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation strategy and use of excipients in pulmonary drug delivery.
    Pilcer G; Amighi K
    Int J Pharm; 2010 Jun; 392(1-2):1-19. PubMed ID: 20223286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring total and regional lung deposition using inhaled radiotracers.
    Dolovich MB
    J Aerosol Med; 2001; 14 Suppl 1():S35-44. PubMed ID: 11424892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SPECT Imaging for Radioaerosol Deposition and Clearance Studies.
    Eberl S; Chan HK; Daviskas E
    J Aerosol Med; 2006; 19(1):8-20. PubMed ID: 16551210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aerosol deposition in the human lung in reduced gravity.
    Darquenne C
    J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):170-7. PubMed ID: 24870702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.